Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Monday, December 10, 2012 | ENZO Biochem Reports First Quarter Results Progress Being Realized in New Products, Efficiencies, Wider Marketing and Cash Utilization, Although Hurricane Sandy Had Temporary Impact on Clinical Labs |
Friday, December 07, 2012 | 2012 Annual Report and Proxy Materials |
Thursday, December 06, 2012 | ENZO Biochem Schedules Teleconference To Discuss First Quarter Results On December 11, 2012 At 8:30 AM E.T. |
Thursday, November 29, 2012 | Biochem To Present At Canaccord Genuity 2012 Medical Technology & Diagnostics Forum |
Tuesday, November 13, 2012 | Biochem’s Clinical Labs Introduces Diagnostic Test That Assists In Early Detection Of Lung Cancer |
Tuesday, November 13, 2012 | ENZO Biochem To Present At Lazard Capital Markets 9th Annual Healthcare Conference |
Friday, November 02, 2012 | Biochem Reports Jury Declares Life Technologies Infringed Company Patents And Awards Enzo $48.6 Million Court To Decide Additional Pre-Judgment Award |
Monday, October 15, 2012 | ENZO Biochem Reports Fourth Quarter Results and Announces Realignment Program Expected To Reduce Annualized Costs $6 Million Commencing With Fiscal First Quarter |
Monday, June 11, 2012 | Enzo Biochem Reports Fiscal Third Quarter Results Growth at Clinical Labs Drives Sequential Quarterly Revenue Growth and Improved Operating Results |
Thursday, May 17, 2012 | Lab Work A new diagnostic system from Enzo Biochem detects multiple diseases from a single sample. |
Tuesday, April 10, 2012 | ENZO Biochem Launch of Test for Measuring Risk of Colorectal Cancer Underscores Growing Role of Molecular Diagnostics Company Developing Pipeline of New Platforms and Assays For Molecular Diagnostic Use |
Sunday, April 01, 2012 | ENZO Biochem Presents New Ampiprobe™ Nucleic Acid Amplification Platform Details At Escmid London Meeting Data Suggests Highly Efficient and Economic Platform Could Be Basis For Next-Generation Molecular Diagnostics |
Tuesday, March 20, 2012 | ENZO Biochem Announces Expanded Distribution Agreement with Japan’s Cosmo Bio New Pact Broadens Life Sciences Unit Presence in Pacific Rim |
Tuesday, March 13, 2012 | ENZO Biochem’s Clinical Laboratory Applies For NY State Health Department Approval For First Assay Based On Its Ampiprobe™ Amplification Platform Highly Efficient Economic Test Also Provides Greater Sensitivity than Conventional Pcr-Based Assays Other Ampiprobe™ Platform-Based Assays in Development For Nucleic Acid Testing Market |
Monday, March 12, 2012 | ENZO Biochem Reports Improved Second Quarter Results |
Thursday, March 08, 2012 | ENZO Biochem Schedules Teleconference to Discuss 2012 Second Quarter Results on March 13, 2012 at 8:30 Am E.T. |
Tuesday, February 21, 2012 | ENZO Biochem Receives Approval For Novel Blood Based Test for Colorectal Cancer Risk New York State Approves Colonsentry™ RNA Expression Assay First In Pipeline Of Unique Products To Be Offered Through Company’s Clinical Laboratory |
Friday, February 10, 2012 | ENZO Biochem to Present At 2012 Leerink Swann Global Healthcare Conference |